Documents

Strong Q1 growth, resilient margins, and strategic expansion despite wage headwinds.

Exceptional FY 2026 growth with strong margins; FY 2027 guided for double-digit organic growth.

AI-led transformation and deep domain expertise drive growth and expand market opportunities.

AI-driven healthcare operations and strong financial growth position the firm as an industry leader.

Exceptional Q3 growth and raised FY26 guidance, with margins steady amid industry pressures.

Q2 and H1 FY26 delivered strong growth, margin expansion, and raised guidance amid AI-led transformation.

Strong Q1 growth, margin expansion, and AI-driven efficiency support raised FY26 outlook.

Strong FY25 growth, margin resilience, and BroadPath integration drive positive outlook.

Strong Q3 growth, margin expansion, and EPS-accretive BroadPath acquisition boost outlook.

Q2 FY25 delivered 21.1% YoY revenue growth and 25.5% EBITDA margin, with strong cash flow.